Pioneering compassionate healthcare innovation with accessible, patient-centric AI solutions that prioritize transparency, explainability and ethical AI practices, ensuring improved well-being and trust in our technology.
Supported by the DOD, the CONSORT Multicenter Trial advances reconstructive transplant research, benefiting military Service members, Veterans, their family members, and the broader community recovering from traumatic injury by standardizing procedures and enhancing overall quality of life.
The CONSORT Multicenter Trial is a dedicated endeavor aimed at standardizing and validating clinical practice guidelines (CPGs) and standard operating procedures (SOPs) in eight pivotal areas within both face and hand transplantation. These encompass patient selection criteria, education protocols, surgical techniques, immune system management, outcome measurement, quality of life assessment, rehabilitation plans, and comprehensive patient reporting systems. These exacting standards ensure the safety and efficacy of transplant procedures while propelling the field forward through data-driven protocols and enhanced patient care.
In this monumental effort, Yale University spearheads clinical, administrative, and operational aspects, complemented by WFUHS managing central regulatory and data management responsibilities. Navitas Technologies pioneers VCA-NET, a state-of-the-art decentralized, cloud-based electronic clinical trial management system (eCTMS) meticulously aligned with standardized CPGs and SOPs, poised to address the intricate nuances of hand and face transplantation metrics. Simultaneously, the partnership with the National Academies of Sciences, Engineering, and Medicine (NASEM) further ensures the rigorous development of SOPs and CPGs, upholding the highest standards in reconstructive transplantation research and practice.
We are excited to announce the initiation of the Clinical Organization Network for Standardization of Reconstructive Transplantation (CONSORT), a multicenter consortium funded by the Reconstructive Transplant Research Program (RTRP) with the objective to standardize protocols and clinical practice guidelines for face and hand transplantation.
We invite you to determine whether your VCA Program qualifies to participate in this important initiative as a Clinical Network Site, particularly if it is approved by UNOS/OPTN for face and/or hand transplantation
Pioneering AI-based solutions for ocular trauma, we develop advanced, non-invasive approaches that accelerate healing and restore vision, transforming the landscape of eye care.
EdgeVision: Exploring Deep Learning at the Edge for Ocular Trauma Research.
EdgeVision: Advancing Ocular Trauma Research through Edge-Based Deep Learning Analysis
AI-Driven Insight into Ocular Trauma: Workshop for Protecting Vision and Preserving Sight
Transforming emergency triage with AI-driven reinforcement learning, our cutting-edge approach optimizes resource allocation and response times, elevating the effectiveness of emergency healthcare.
AI-Enhanced Emergency Triage: Optimizing Resource Allocation for Rapid Healthcare Response.
Challenges and Innovations in Emergency Triage with Deep Reinforcement Learning
Workshop on Deep Reinforcement Learning Challenges in Emergency Triage and Advancements in Healthcare Response.
Redefining drug safety with AI-driven solutions for Adverse Interactions, we empower healthcare providers with real-time insights to prevent and manage potential risks, prioritizing patient well-being.
Advancing Drug Safety: AI-Driven Solutions for Adverse Interactions and Real-time Risk Management in Healthcare
Navigating Challenges in Drug Safety with AI-Driven Solutions for Adverse Interactions and Real-time Risk Management in Healthcare
Web Seminar: Addressing Challenges in Drug Safety with AI-Driven Solutions for Adverse Interactions and Real-time Risk Management in Healthcare
By seamlessly integrating deep learning into virtual clinical trials, we empower remote patient monitoring, eliminate logistical barriers, and expedite the assessment of innovative therapies, marking a transformative era in healthcare research.
Empowering Healthcare Research with Deep Learning in Virtual Clinical Trials for Remote Patient Monitoring and Accelerated Therapeutic Assessment.
Exploring Deep Learning Opportunities in Virtual Clinical Trials
Unveiling the Future of Deep Learning in Virtual Clinical Trials – Meetup Talk.
Our ocular trauma facility has witnessed a significant transformation through our collaboration with Navitas. Their cutting-edge AI solutions have streamlined our operations and have the potential to greatly enhance patient care and outcomes.
This AI-powered health tech startup has been instrumental in our combat triage research, accelerating our efforts and enhancing the quality of our work. Their commitment to ethical AI and innovative solutions align perfectly with our mission to improve battlefield care.
This AI-powered health tech company has been a crucial ally in our early sepsis research. Their prototype and AI solutions have the potential to revolutionize early detection, offering hope for better outcomes and saving lives.
As a physician, I'm truly impressed by Navitas Health Tech expertise in applying advanced AI algorithms. Their analytics-driven approach is a game-changer, promising innovation and improved outcomes in my field.
